IS

Isabl

YC W20

New York City, US · Founded 2020 · 5 employees · 2 known investors

isabl.io ↗

Isabl develops whole genome and transcriptome sequencing technology for cancer diagnosis, delivering comprehensive genomic profiling and treatment options to physicians and research teams. The company provides rapid cancer diagnostic tests in clinically relevant timeframes to improve outcomes for cancer patients globally.

Founders & leadership· Y Combinator alumni (W20)

Juan Medinain𝕏Founder

Andrew KungFounder

Elli PapaemmanuilinFounder

Investors · 2

Y

Y Combinator✓ verifiedMountain View · $500K – $500K

EV

Evolution VC Partnersreported